Hasil Pencarian - Thomas Brevig

  • Menampilkan 1 - 10 hasil dari 10
Perbaiki Hasil
  1. 1
    Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists

    Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists oleh Christoph U. Correll, Thomas Brevig, Cecilia Brain

    Diterbitkan 2019-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Neural Xenotransplantation: Pretreatment of Porcine Embryonic Nigral Tissue with Anti-Gal Antibodies and Complement is not Toxic for the Dopaminergic Neurons

    Neural Xenotransplantation: Pretreatment of Porcine Embryonic Nigral Tissue with Anti-Gal Antibodies and Complement is not Toxic for the Dopaminergic Neurons oleh Thomas Brevig, Morten Meyer, Tom Kristensen, Jens Zimmer

    Diterbitkan 2001-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Proliferative Response of Human T Lymphocytes to Porcine Fetal Brain Cells

    Proliferative Response of Human T Lymphocytes to Porcine Fetal Brain Cells oleh Thomas Brevig, Erik B. Pedersen, Tom Kristensen, Jens Zimmer

    Diterbitkan 1997-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Experiences, attitudes, and perceptions of caregivers of individuals with treatment-resistant schizophrenia: a qualitative study

    Experiences, attitudes, and perceptions of caregivers of individuals with treatment-resistant schizophrenia: a qualitative study oleh Cecilia Brain, Steven Kymes, Dana B. DiBenedetti, Thomas Brevig, Dawn I. Velligan

    Diterbitkan 2018-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Activated Porcine Embryonic Brain Endothelial Cells Induce a Proliferative Human T-Lymphocyte Response

    Activated Porcine Embryonic Brain Endothelial Cells Induce a Proliferative Human T-Lymphocyte Response oleh Suchitra Sumitran-Holgersson, Thomas Brevig, Håkan Widner, Jan Holgersson M.D., PH.D.

    Diterbitkan 2003-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Patient-reported outcomes, health-related quality of life, and acute medication use in patients with a ≥ 75% response to eptinezumab: subgroup pooled analysis of the PROMISE trials

    Patient-reported outcomes, health-related quality of life, and acute medication use in patients with a ≥ 75% response to eptinezumab: subgroup pooled analysis of the PROMISE trials... oleh Richard B. Lipton, Larry Charleston, Cristina Tassorelli, Thomas Brevig, Joe Hirman, Roger Cady

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Early response to eptinezumab indicates high likelihood of continued response in patients with chronic migraine

    Early response to eptinezumab indicates high likelihood of continued response in patients with chronic migraine oleh Dawn C. Buse, Paul K. Winner, Larry Charleston, Joe Hirman, Roger Cady, Thomas Brevig

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study

    Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study oleh Robert P. Cowan, Michael J. Marmura, Hans-Christoph Diener, Amaal J. Starling, Jack Schim, Joe Hirman, Thomas Brevig, Roger Cady

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials

    Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials oleh Timothy R. Smith, Egilius L. H. Spierings, Roger Cady, Joe Hirman, Barbara Schaeffler, Vivienne Shen, Bjørn Sperling, Thomas Brevig, Mette Krog Josiassen, Elizabeth Brunner, Loan Honeywell, Lahar Mehta

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials

    Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials oleh Timothy R. Smith, Egilius L. H. Spierings, Roger Cady, Joe Hirman, Barbara Schaeffler, Vivienne Shen, Bjørn Sperling, Thomas Brevig, Mette Krog Josiassen, Elizabeth Brunner, Loan Honeywell, Lahar Mehta

    Diterbitkan 2021-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: